|
Ackerman, L. S. (2006). "Sex hormones and the genesis of autoimmunity." Arch Dermatol 142(3): 371-6. Ahmad, Y. A. and I. N. Bruce (2001). "Genetic epidemiology: systemic lupus erythematosus." Arthritis Res 3(6): 331-6. Epub 2001 Aug 23. Amit, M., Y. Molad, et al. (1997). "Seasonal variations in manifestations and activity of systemic lupus erythematosus." Br J Rheumatol 36(4): 449-52. Arend, W. P. (2002). "The balance between IL-1 and IL-1Ra in disease." Cytokine Growth Factor Rev 13(4-5): 323-40. Arend, W. P. and C. J. Guthridge (2000). "Biological role of interleukin 1 receptor antagonist isoforms." Ann Rheum Dis 59 Suppl 1: i60-4. Arend, W. P., M. Malyak, et al. (1998). "Interleukin-1 receptor antagonist: role in biology." Annu Rev Immunol 16: 27-55. Bennett, F., D. Luxenberg, et al. (2003). "Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses." J Immunol 170(2): 711-8. Bennett, F., D. Luxenberg, et al. (2003). "Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses." J Immunol 170(2): 711-8. Bensen, J. T., C. D. Langefeld, et al. (2003). "Nucleotide variation, haplotype structure, and association with end-stage renal disease of the human interleukin-1 gene cluster." Genomics 82(2): 194-217. Bettinotti, M. P., K. Hartung, et al. (1993). "Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes." Immunogenetics 37(6): 449-54. Blakemore, A. I., A. Cox, et al. (1996). "Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus." Hum Genet 97(3): 369-74. Blakemore, A. I., J. K. Tarlow, et al. (1994). "Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus." Arthritis Rheum 37(9): 1380-5. Bombardier, C., D. D. Gladman, et al. (1992). "Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE." Arthritis Rheum 35(6): 630-40. Botstein, D. and N. Risch (2003). "Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease." Nat Genet 33 Suppl: 228-37. Burlingame, R. W. and R. L. Rubin (1996). "Autoantibody to the nucleosome subunit (H2A-H2B)-DNA is an early and ubiquitous feature of lupus-like conditions." Mol Biol Rep 23(3-4): 159-66. Carter, D. B., M. R. Deibel, Jr., et al. (1990). "Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein." Nature 344(6267): 633-8. Cervera, R., M. Abarca-Costalago, et al. (2006). "Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project"." Autoimmun Rev 5(3): 180-6. Epub 2005 Jul 26. Chen, C. Y., H. M. Tseng, et al. (2003). "Use of a new fluorescence immunoassay to detect anti-dsDNA antibodies is more correlated with disease activity and complement than the ELISA method in SLE patients." Lupus 12(4): 266-73. Cohen, S. B. (2004). "The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis." Rheum Dis Clin North Am 30(2): 365-80, vii. Coller, J. and R. Parker (2004). "Eukaryotic mRNA decapping." Annu Rev Biochem 73: 861-90. Croker, B. P., G. Gilkeson, et al. (2003). "Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupus." Genes Immun 4(8): 575-85. D'Cruz, D. (2000). "Autoimmune diseases associated with drugs, chemicals and environmental factors." Toxicol Lett 112-113: 421-32. Davas, E. M., A. Tsirogianni, et al. (1999). "Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus." Clin Rheumatol 18(1): 17-22. Deb, T. B. and K. Datta (1996). "Molecular cloning of human fibroblast hyaluronic acid-binding protein confirms its identity with P-32, a protein co-purified with splicing factor SF2. Hyaluronic acid-binding protein as P-32 protein, co-purified with splicing factor SF2." J Biol Chem 271(4): 2206-12. di Giovine, F. S., E. Takhsh, et al. (1992). "Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta)." Hum Mol Genet 1(6): 450. Dinarello, C. A. (2004). "Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation." Curr Opin Pharmacol 4(4): 378-85. Doan, B. Q., A. J. Sorant, et al. (2006). "Covariate-based linkage analysis: application of a propensity score as the single covariate consistently improves power to detect linkage." Eur J Hum Genet. 2006 May 31. El-Omar, E. M., M. Carrington, et al. (2000). "Interleukin-1 polymorphisms associated with increased risk of gastric cancer." Nature 404(6776): 398-402. Finks, S. W., A. L. Finks, et al. (2006). "Hydralazine-induced lupus: maintaining vigilance with increased use in patients with heart failure." South Med J 99(1): 18-22. Fisher, S. A., A. Moody, et al. (2003). "Genetic variation at the chromosome 16 chemokine gene cluster: development of a strategy for association studies in complex disease." Ann Hum Genet 67(Pt 5): 377-90. Fleischmann, R. M., I. Iqbal, et al. (2004). "Considerations with the use of biological therapy in the treatment of rheumatoid arthritis." Expert Opin Drug Saf 3(5): 391-403. Flierman, R. and M. R. Daha (2006). "Pathogenic role of anti-C1q autoantibodies in the development of lupus nephritis-a hypothesis." Mol Immunol. 2006 Jul 24. Garat, C. and W. P. Arend (2003). "Intracellular IL-1Ra type 1 inhibits IL-1-induced IL-6 and IL-8 production in Caco-2 intestinal epithelial cells through inhibition of p38 mitogen-activated protein kinase and NF-kappaB pathways." Cytokine 23(1-2): 31-40. Govoni, M., G. Castellino, et al. (2006). "Incidence and prevalence of systemic lupus erythematosus in a district of north Italy." Lupus 15(2): 110-3. Guzman, J., M. H. Cardiel, et al. (1992). "Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices." J Rheumatol 19(10): 1551-8. Haga, H. J., J. G. Brun, et al. (1999). "Seasonal variations in activity of systemic lupus erythematosus in a subarctic region." Lupus 8(4): 269-73. Hasan, T., M. Pertovaara, et al. (2004). "Seasonal variation of disease activity of systemic lupus erythematosus in Finland: a 1 year follow up study Seasonal variations in manifestations and activity of systemic lupus erythematosus." Ann Rheum Dis 63(11): 1498-500. Heidema, A. G., J. M. Boer, et al. (2006). "The challenge for genetic epidemiologists: how to analyze large numbers of SNPs in relation to complex diseases." BMC Genet 7: 23. Hochberg, M. C. (1997). "Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus." Arthritis Rheum 40(9): 1725. Horak, P., Z. Hermanova, et al. (2006). "C1q complement component and -antibodies reflect SLE activity and kidney involvement." Clin Rheumatol 25(4): 532-6. Epub 2005 Nov 26. Horne, B. D., J. F. Carlquist, et al. (2006). "High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene." Ann Hum Genet 70(Pt 4): 524-34. Houghton, K. M., J. Page, et al. (2006). "Systemic lupus erythematosus in the pediatric North American Native population of British Columbia." J Rheumatol 33(1): 161-3. Huang, C. M., M. C. Wu, et al. (2002). "Interleukin-1 receptor antagonist gene polymorphism in chinese patients with systemic lupus erythematosus." Clin Rheumatol 21(3): 255-7. Huang, C. M., M. C. Wu, et al. (2002). "Interleukin-1 receptor antagonist gene polymorphism in chinese patients with systemic lupus erythematosus." Clin Rheumatol 21(3): 255-7. Huang, C. M., M. C. Wu, et al. (2002). "Lack of association of interleukin-1beta gene polymorphisms in Chinese patients with systemic lupus erythematosus." Rheumatol Int 21(5): 173-5. Hung, S. I., W. H. Chung, et al. (2005). "HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol." Proc Natl Acad Sci U S A 102(11): 4134-9. Hurme, M. and S. Santtila (1998). "IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes." Eur J Immunol 28(8): 2598-602. Ionita, I. and M. Man (2006). "Optimal two-stage strategy for detecting interacting genes in complex diseases." BMC Genet 7(1): 39. Johansson, M., L. Arlestig, et al. (2005). "Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus." Arthritis Rheum 52(6): 1665-9. Joos, L., L. McIntyre, et al. (2001). "Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers." Thorax 56(11): 863-6. Karhukorpi, J., T. Laitinen, et al. (2003). "IL-1 receptor antagonist gene polymorphism in recurrent spontaneous abortion." J Reprod Immunol 58(1): 61-7. Kasapcopur, O., Y. Ergul, et al. (2005). "Systemic lupus erythematosus due to Epstein-Barr virus or Epstein-Barr virus infection provocating acute exacerbation of systemic lupus erythematosus?" Rheumatol Int: 1-3. Kelly, J. A., K. L. Moser, et al. (2002). "The genetics of systemic lupus erythematosus: putting the pieces together." Genes Immun 3 Suppl 1: S71-85. Kiberd, B. A. and A. W. Stadnyk (1995). "Established murine lupus nephritis does not respond to exogenous interleukin-1 receptor antagonist; a role for the endogenous molecule?" Immunopharmacology 30(2): 131-7. Kuhn, A., M. Herrmann, et al. (2006). "Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation." Arthritis Rheum 54(3): 939-50. Lane, S. K. and J. W. Gravel, Jr. (2002). "Clinical utility of common serum rheumatologic tests." Am Fam Physician 65(6): 1073-80. Lee, Y. H., J. B. Harley, et al. (2006). "Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility." Eur J Hum Genet 14(3): 364-71. Lin, C. Y., C. C. Hsieh, et al. (2001). "The underlying diseases and follow-up in Taiwanese children screened by urinalysis." Pediatr Nephrol 16(3): 232-7. Lin, C. Y., C. C. Hsieh, et al. (2001). "The underlying diseases and follow-up in Taiwanese children screened by urinalysis." Pediatr Nephrol 16(3): 232-7. Liou, L. B. (2001). "Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients." Clin Exp Rheumatol 19(5): 515-23. Maeshima, E., X. M. Liang, et al. (2002). "Effect of environmental changes on oxidative deoxyribonucleic acid (DNA) damage in systemic lupus erythematosus." Arch Environ Health 57(5): 425-8. Malyak, M., J. M. Guthridge, et al. (1998). "Characterization of a low molecular weight isoform of IL-1 receptor antagonist." J Immunol 161(4): 1997-2003. Mao, X. Q., M. Kawai, et al. (2000). "Imbalance production between interleukin-1beta (IL-1beta) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma." Biochem Biophys Res Commun 276(2): 607-12. Marculescu, R., G. Endler, et al. (2002). "Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes." Diabetes 51(12): 3582-5. Marshall, E. (2002). "Lupus: mysterious disease holds its secrets tight." Science 296(5568): 689-91. McCarthy, M. I. (2002). "Susceptibility gene discovery for common metabolic and endocrine traits." J Mol Endocrinol 28(1): 1-17. McGrath, H., Jr. (1999). "Ultraviolet A1 (340-400 nm) irradiation and systemic lupus erythematosus." J Investig Dermatol Symp Proc 4(1): 79-84. Messer, G., U. Spengler, et al. (1991). "Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production." J Exp Med 173(1): 209-19. Mok, C. C. and C. S. Lau (2003). "Pathogenesis of systemic lupus erythematosus." J Clin Pathol 56(7): 481-90. Nakae, S., M. Asano, et al. (2001). "Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production." Immunology 104(4): 402-9. Nakae, S., M. Asano, et al. (2001). "Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production." Immunology 104(4): 402-9. Nicklin, M. J., J. L. Barton, et al. (2002). "A sequence-based map of the nine genes of the human interleukin-1 cluster." Genomics 79(5): 718-25. Ostendorf, B., C. Iking-Konert, et al. (2005). "Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis." Ann Rheum Dis 64(4): 630-3. Padyukov, L., J. Lampa, et al. (2003). "Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis." Ann Rheum Dis 62(6): 526-9. Parks, C. G., G. S. Cooper, et al. (2004). "Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States." Ann Rheum Dis 63(1): 91-4. Parks, C. G., G. S. Cooper, et al. (2004). "Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States." Ann Rheum Dis 63(1): 91-4. Perrier, S., C. Coussediere, et al. (1998). "IL-1 receptor antagonist (IL-1RA) gene polymorphism in Sjogren's syndrome and rheumatoid arthritis." Clin Immunol Immunopathol 87(3): 309-13. Poole, B. D., R. H. Scofield, et al. (2006). "Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus." Autoimmunity 39(1): 63-70. Prokunina, L., C. Castillejo-Lopez, et al. (2002). "A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans." Nat Genet 32(4): 666-9. Raj, D., D. E. Brash, et al. (2006). "Keratinocyte apoptosis in epidermal development and disease." J Invest Dermatol 126(2): 243-57. Saccone, S. F., J. P. Rice, et al. (2006). "Power-based, phase-informed selection of single nucleotide polymorphisms for disease association screens." Genet Epidemiol. 2006 May 9. Santtila, S., K. Savinainen, et al. (1998). "Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro." Scand J Immunol 47(3): 195-8. Sarzi-Puttini, P., F. Atzeni, et al. (2005). "Drug-induced lupus erythematosus." Autoimmunity 38(7): 507-18. Scheinfeld, N. and V. A. Deleo (2004). "Photosensitivity in lupus erythematosus." Photodermatol Photoimmunol Photomed 20(5): 272-9. Schrijver, H. M., J. B. Crusius, et al. (1999). "Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS." Neurology 52(3): 595-9. Shen, H., J. L. Kan, et al. (2004). "Arginine-serine-rich domains bound at splicing enhancers contact the branchpoint to promote prespliceosome assembly." Mol Cell 13(3): 367-76. Shirai, T., H. Nishimura, et al. (2002). "Genome screening for susceptibility loci in systemic lupus erythematosus." Am J Pharmacogenomics 2(1): 1-12. Skaer, T. L. (1992). "Medication-induced systemic lupus erythematosus." Clin Ther 14(4): 496-506; discussion 495. Spielman, R. S., R. E. McGinnis, et al. (1993). "Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM)." Am J Hum Genet 52(3): 506-16. Steinkasserer, A., K. Koelble, et al. (1991). "Length variation within intron 2 of the human IL-1 receptor antagonist protein gene (IL1RN)." Nucleic Acids Res 19(18): 5095. Steinsson, K., S. Jonsdottir, et al. (1998). "A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland." Ann Rheum Dis 57(8): 503-5. Sturfelt, G. (2002). "The complement system in systemic lupus erythematosus." Scand J Rheumatol 31(3): 129-32. Sturfelt, G., P. Roux-Lombard, et al. (1997). "Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosus." Br J Rheumatol 36(12): 1283-9. Stylianou, E. and J. Saklatvala (1998). "Interleukin-1." Int J Biochem Cell Biol 30(10): 1075-9. Sullivan, K. E., A. F. Jawad, et al. (2003). "Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus." Rheumatology (Oxford) 42(3): 446-52. Tan, E. M., A. S. Cohen, et al. (1982). "The 1982 revised criteria for the classification of systemic lupus erythematosus." Arthritis Rheum 25(11): 1271-7. Tarlow, J. K., A. I. Blakemore, et al. (1993). "Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat." Hum Genet 91(4): 403-4. Tartour, E., R. S. Lee, et al. (1994). "Anti-cytokines: promising tools for diagnosis and immunotherapy." Biomed Pharmacother 48(10): 417-24. Theofilopoulos, A. N. and D. H. Kono (2002). "A genetic analysis of lupus." Allergy 57 Suppl 72: 67-74. Tobon, G. J., P. A. Correa, et al. (2005). "Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjogren's syndrome." Clin Exp Rheumatol 23(3): 339-44. Tokunaga, K., W. J. Zhang, et al. (1991). "The genomic structure of two ancestral haplotypes carrying C4A duplications." Immunogenetics 34(4): 247-51. Trendelenburg, M., M. Lopez-Trascasa, et al. (2006). "High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis." Nephrol Dial Transplant. 2006 Jul 28. Tsao, B. P. (2002). "An update on genetic studies of systemic lupus erythematosus." Curr Rheumatol Rep 4(4): 359-67. Tsao, B. P. and J. M. Grossman (2001). "Genetics and systemic lupus erythematosus." Curr Rheumatol Rep 3(3): 183-90. Tsokos, G. C. (2001). "Systemic lupus erythematosus. A disease with a complex pathogenesis." Lancet 358 Suppl: S65. Vamvakopoulos, J., C. Green, et al. (2002). "Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist." Eur J Immunol 32(10): 2988-96. Vamvakopoulos, J. E., C. J. Taylor, et al. (2002). "The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism." Eur J Immunogenet 29(4): 337-40. Wais, T., W. Fierz, et al. (2003). "Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission." J Rheumatol 30(10): 2133-9. Watanabe, M., M. Iwano, et al. (2002). "Association of interleukin-1 receptor antagonist gene polymorphism with IgA nephropathy." Nephron 91(4): 744-6. Waterston, A. M., F. Salway, et al. (2004). "TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model." Br J Cancer 90(6): 1279-84. Waterston, A. M., F. Salway, et al. (2004). "TNF autovaccination induces self anti-TNF antibodies and inhibits metastasis in a murine melanoma model." Br J Cancer 90(6): 1279-84. Yue, P., E. Melamud, et al. (2006). "SNPs3D: candidate gene and SNP selection for association studies." BMC Bioinformatics 7: 166. Zandman-Goddard, G. and Y. Shoenfeld (2005). "Infections and SLE." Autoimmunity 38(7): 473-85.
|